Absci Corporation
NASDAQ:ABSIBiotechnology
+$0.08 today
- Market cap
- $1.41B
- Beta
- 2.46
- P/E (TTM)
- -9.4
- EPS (TTM)
- -$0.77
Volume 5.66M
Average 5.10M
ABSI Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Absci CorporationNASDAQ: ABSI
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 15.9% from a year ago
Total assets stood at $195.59M at the end of Q1 FY2026, down 15.9% from a year earlier and down 9.6% from the prior quarter. Over 3 fiscal years it compounded at -12.3% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -15.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 216.3M USD
- Year-over-year change
- +1.3%
- 4-year CAGR
- -15.6%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 216.3M | +1.3% |
| FY2024 | 2024-12-31 | 213.61M | -1.7% |
| FY2023 | 2023-12-31 | 217.3M | -32.3% |
| FY2022 | 2022-12-31 | 321.01M | -24.7% |
| FY2021 | 2021-12-31 | 426.2M | — |
Total Assets vs competitors
How ABSI compares with its peers on the latest reported figures
- ABSI's Mar 2026 total assets of $195.59M is the lowest of the 3 companies compared; the peer median is $1.06B.
- Its year-over-year change of -15.9% is the lowest of 2, against a peer median of +10.6%.
- Over three fiscal years its annual growth of -12.3% compares with a peer median of -4.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Sep 2026 | $1.5B | +10.6% | -4.1% | |
GENBGenerate Biomedicines, Inc. | Mar 2026 | $625.74M | — | — |
| Mar 2026 | $195.59M | -15.9% | -12.3% | |
| Peer median (excluding ABSI) | $1.06B | +10.6% | -4.1% | |
Competitors are the stored peer set for ABSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 252.57M | 59.96M | 72.36M | 41.21M | 20.03M |
| Short-term Investments | 0 | 104.48M | 25.3M | 71.21M | 124.27M |
| Net Receivables | 1.43M | 1.55M | 2.19M | 0 | 0 |
| Inventory | 10.51M | 15.02M | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 20.73M | 21.41M | 5.28M |
| Total Current Assets | 273.08M | 186.86M | 120.58M | 133.83M | 149.57M |
| Property, Plant & Equipment (Net) | 58.65M | 58.04M | 45.82M | 33.14M | 23.77M |
| Goodwill | 21.34M | 21.34M | 0 | 0 | 0 |
| Intangible Assets | 54.99M | 51.62M | 48.25M | 44.88M | 41.51M |
| Long-term Investments | 16.84M | 1.86M | 0 | 0 | 0 |
| Tax Assets | (16.84M) | 17.66M | 0 | 0 | 0 |
| Other Non-current Assets | 18.14M | (16.38M) | 2.65M | 1.76M | 1.44M |
| Total Non-current Assets | 153.12M | 134.15M | 96.72M | 79.78M | 66.72M |
| Total Assets | 426.2M | 321.01M | 217.3M | 213.61M | 216.3M |
| Account Payables | 8.39M | 2.41M | 1.5M | 3.53M | 2.76M |
| Short-term Debt | 2.4M | 2.95M | 3.26M | 2.73M | 873K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.35M | 445K | 3.17M | 1.12M | 739K |
| Other Current Liabilities | 0 | 0 | 12.75M | 12.75M | 0 |
| Total Current Liabilities | 33.86M | 30.27M | 29.56M | 28.66M | 22.77M |
| Long-term Debt | 1.12M | 7.98M | 4.66M | 1.26M | 0 |
| Deferred Tax Liabilities | 743K | 238K | 186K | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 966K | 0 | 436K |
| Other Non-current Liabilities | 12.16M | 35K | 109K | 133K | 1.02M |
| Total Non-current Liabilities | 26.23M | 16.32M | 11.56M | 5.82M | 4.08M |
| Total Liabilities | 60.09M | 46.59M | 41.12M | 34.48M | 26.85M |
| Common Stock | 9K | 9K | 9K | 12K | 15K |
| Retained Earnings | (191.03M) | (295.93M) | (406.5M) | (509.6M) | (624.78M) |
| Accumulated OCI | (13K) | (120K) | (37K) | (4K) | 591K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 366.11M | 274.41M | 176.18M | 179.13M | 189.45M |
| Total Debt | 20.01M | 22.98M | 15.88M | 10.11M | 5.3M |
| Net Debt | (232.56M) | (36.97M) | (56.48M) | (31.11M) | (14.72M) |
Absci Corporation
NASDAQ:ABSI
Intrinsic Alpha fair value
Locked
Current Price
$8.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.